Similar articles

• [Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].

  Náhunek K, Hádlík J, Rodová A, Misurec J, Vanýsek J. Náhunek K, et al. Act Nerv Super (Praha). 1970 Jan 12;12(1):56-7. Act Nerv Super (Praha). 1970. PMID: 4907390 Clinical Trial. Czech. No abstract available.
• [Clinical results with trifluoperidol in schizophrenic patients].

  Navarro MP, Assis LM, Martins C. Navarro MP, et al. Rev Assoc Med Bras. 1966 Dec;12(12):497-501. Rev Assoc Med Bras. 1966. PMID: 5241539 Portuguese. No abstract available.
• Evaluation of trifluperidol in chronic schizaphrenia.

  Clark ML, Huber WK, Kyriakopoulos AA, Ray TS, Colmore JP, Ramsey HR. Clark ML, et al. Psychopharmacologia. 1968;12(3):193-203. Psychopharmacologia. 1968. PMID: 4917285 Clinical Trial. No abstract available.
• [Psychosis and chronic delirium].

  Pontonnier AL, Jalenques I. Pontonnier AL, et al. Rev Prat. 2008 Feb 29;58(4):425-33. Rev Prat. 2008. PMID: 18506985 Review. French. No abstract available.
• The evolution of the butyrophenones, haloperidol and trifluperidol, from meperidine-like 4-phenylpiperidines.

  Janssen PA. Janssen PA. Int Rev Neurobiol. 1965;8:221-63. doi: 10.1016/s0074-7742(08)60759-x. Int Rev Neurobiol. 1965. PMID: 5321473 Review. No abstract available.